Measure to remove hormonal medications from prescription monitoring program passes Senate committee
A proposal to remove testosterone from the current prescription monitoring program, as well as preemptively prevent the inclusion of medicines for gender-affirming or reproductive healthcare on the program, is one step closer to law after being approved Wednesday by a Senate committee.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
